Che-Kai Tsao, MD, MS, discusses new approaches that could change the standard of care for metastatic hormone-sensitive prostate cancer.
Che-Kai Tsao, MD, MS
Che-Kai Tsao, MD, MS, is system chief of Solid Tumor Oncology at Northwell Health Cancer Institute.
Articles by Che-Kai Tsao, MD, MS
Che-Kai Tsao, MD, MS, discusses the current state of treatment for metastatic hormone-sensitive prostate cancer.
Latest Updated Articles
Disease Factors Can Support Intensification or Deescalation in HSPCPublished: November 17th 2025 | Updated: